Leveraged & Inverse ChannelOmicron Variant Is Boosting This Leveraged Biotech ETFBy Ben HernandezDecember 15, 2021
Leveraged & Inverse ChannelLatest Bills on Capitol Hill Tee Up Trades in These Two ETFsBy Ben HernandezNovember 8, 2021
Leveraged & Inverse ChannelTailwinds Are Blowing Behind Healthcare and the “CURE” ETFBy Ben HernandezSeptember 3, 2021
Leveraged & Inverse Channel3 ETFs to Access a Changing Pharmaceutical IndustryBy Ben HernandezAugust 16, 2021
Leveraged & Inverse ChannelExtra Bullish on Healthcare? Consider Leverage, the CURE ETFBy Ben HernandezAugust 2, 2021
Leveraged & Inverse ChannelTrading the Spending Supercycle. A $2.3 Trillion Dollar Opportunity.By DirexionApril 14, 2021
Leveraged & Inverse ChannelBiden’s Infrastructure Can Put These 2 Leveraged Funds in PlayBy Ben HernandezApril 9, 2021
Multi-Factor ChannelRising Coronavirus Numbers Makes Case for this Healthcare ETFBy Ben HernandezJuly 7, 2020
Leveraged & Inverse ChannelHealthcare ETFs Are Hot Right Now, but Not All Are Created EqualBy Ben HernandezApril 27, 2020
Leveraged & Inverse ChannelHealth Care ETFs Could be Cure for Trade War BluesBy Ben HernandezMay 29, 2019
Relative Value ChannelWill Tighter Government Regulation Test Health Care ETFs?By Ben HernandezApril 15, 2019
Leveraged & Inverse ChannelHealth Care ETFs Get a Boost From Latest Jobs ReportBy Ben HernandezApril 6, 2019
Leveraged & Inverse ChannelThings Are About to Get Interesting For Healthcare Leveraged ETFBy Brenton GarenJanuary 18, 2019
Leveraged & Inverse ChannelRising U.S. Health Care Spending a Boon to this Leveraged ETFBy Ben HernandezJanuary 8, 2019
Leveraged & Inverse ChannelLeveraged Healthcare ETF Gains On Midterm Election ResultsBy Ben HernandezNovember 7, 2018
Leveraged & Inverse Channel3 Midterm Election Issues that Could Move Leveraged Healthcare ETFBy Ben HernandezNovember 6, 2018
Leveraged & Inverse ChannelPharma Earnings: The PILL to CURE Market Troubles?By DirexionNovember 1, 2018
Leveraged & Inverse ChannelAn Adventurous Idea For Healthcare Earnings SeasonBy Brenton GarenOctober 4, 2018
